Eli Lilly LLY
NYSE LLY
$1,445.40 +14.66 (+1.02%)
At close: Nov 13, 2026 · 4:00 PM EST

Eli Lilly (LLY) Other Accumulated Expenses (2009 - 2026)

Updated

Eli Lilly's Other Accumulated Expenses came in at $12.22 billion for Q3 2026, up 134.4% from $5.22 billion a year earlier and up 4.8% from the prior quarter.

Analysis

Eli Lilly (LLY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

At the end of FY2025, Eli Lilly's Other Accumulated Expenses was $8.46 billion, up 32.2% from FY2024.

  • Other Accumulated Expenses has increased in each of the last three years, with a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $6.4 billion in FY2024 (+95.0%), $3.28 billion in FY2023 (+15.3%), $2.85 billion in FY2022 (-6.0%) and $3.03 billion in FY2021 (+10.1%).
  • The Q3 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q2 2009.
  • Year-over-year, Other Accumulated Expenses has increased for four consecutive quarters, with growth averaging 65.6% over the last eight quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2026 (growth of 134.4%), and the weakest in Q2 2022 (a decline of 23.7%).
  • Business Quant data shows LLY's Other Accumulated Expenses at $11.66 billion (Q2 2026), $8.7 billion (Q1 2026) and $8.46 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.22 Bn
Jun 30, 2026 11.66 Bn
Mar 31, 2026 8.70 Bn
Dec 31, 2025 8.46 Bn
Sep 30, 2025 5.22 Bn
Jun 30, 2025 5.08 Bn
Mar 31, 2025 3.77 Bn
Dec 31, 2024 6.40 Bn
Sep 30, 2024 5.58 Bn
Jun 30, 2024 4.25 Bn
Mar 31, 2024 4.20 Bn
Dec 31, 2023 3.28 Bn
Sep 30, 2023 2.59 Bn
Jun 30, 2023 2.27 Bn
Mar 31, 2023 2.19 Bn
Dec 31, 2022 2.85 Bn
Sep 30, 2022 1.99 Bn
Jun 30, 2022 2.00 Bn
Mar 31, 2022 2.54 Bn
Dec 31, 2021 3.03 Bn
API Access

Eli Lilly Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LLY&period=max&api_key=YOUR_API_KEY